Global Drug Safety Solutions and Pharmacovigilance Market Insights, Forecast to 2029
This report presents an overview of global market for Drug Safety Solutions and Pharmacovigilance market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Drug Safety Solutions and Pharmacovigilance, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Safety Solutions and Pharmacovigilance, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Safety Solutions and Pharmacovigilance revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Drug Safety Solutions and Pharmacovigilance market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Drug Safety Solutions and Pharmacovigilance revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube and Covance Inc., etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Safety Solutions and Pharmacovigilance in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety Solutions and Pharmacovigilance companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Safety Solutions and Pharmacovigilance revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Drug Safety Solutions and Pharmacovigilance, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Safety Solutions and Pharmacovigilance, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Safety Solutions and Pharmacovigilance revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Drug Safety Solutions and Pharmacovigilance market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Drug Safety Solutions and Pharmacovigilance revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube and Covance Inc., etc.
By Company
- Pharmaceutical Product Development, LLC
- Drug Safety Solutions Limited
- C3i
- Worldwide Clinical Trials
- Bioclinica
- United Biosource LLC
- Ennov
- AB Cube
- Covance Inc.
- Accenture
- PRA Health Sciences, Inc.
- Ergomed
- IQVIA
- Genpact
- Cognizant
- Parexel International Corporation
- ArisGlobal
- ICON plc
- Oracle
- Syneos Health
- Standard Form
- Customized Form
- Biotechnology and Pharmaceuticals
- Contract Research Organization (CROS)
- Hospital
- KPO / BPO
- Healthcare Institutions
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Safety Solutions and Pharmacovigilance in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety Solutions and Pharmacovigilance companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Safety Solutions and Pharmacovigilance revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Standard Form
1.2.3 Customized Form
1.3 Market by Application
1.3.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization (CROS)
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Drug Safety Solutions and Pharmacovigilance Market Perspective (2018-2029)
2.2 Global Drug Safety Solutions and Pharmacovigilance Growth Trends by Region
2.2.1 Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Size by Region (2018-2023)
2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2024-2029)
2.3 Drug Safety Solutions and Pharmacovigilance Market Dynamics
2.3.1 Drug Safety Solutions and Pharmacovigilance Industry Trends
2.3.2 Drug Safety Solutions and Pharmacovigilance Market Drivers
2.3.3 Drug Safety Solutions and Pharmacovigilance Market Challenges
2.3.4 Drug Safety Solutions and Pharmacovigilance Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Drug Safety Solutions and Pharmacovigilance by Players
3.1.1 Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2018-2023)
3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2018-2023)
3.2 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio
3.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2022
3.5 Global Key Players of Drug Safety Solutions and Pharmacovigilance Head office and Area Served
3.6 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
3.7 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE BREAKDOWN DATA BY TYPE
4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2018-2023)
4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2024-2029)
5 DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE BREAKDOWN DATA BY APPLICATION
5.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2018-2023)
5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
6.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type
6.2.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
6.2.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
6.2.3 North America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application
6.3.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
6.3.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
6.3.3 North America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
6.4 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country
6.4.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023)
6.4.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
7.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type
7.2.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
7.2.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
7.2.3 Europe Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application
7.3.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
7.3.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
7.3.3 Europe Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
7.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country
7.4.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023)
7.4.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
8.2 China Drug Safety Solutions and Pharmacovigilance Market Size by Type
8.2.1 China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
8.2.2 China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
8.2.3 China Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
8.3 China Drug Safety Solutions and Pharmacovigilance Market Size by Application
8.3.1 China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
8.3.2 China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
8.3.3 China Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
9.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type
9.2.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
9.2.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
9.2.3 Asia Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
9.3 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application
9.3.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
9.3.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
9.3.3 Asia Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
9.4 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region
9.4.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2023)
9.4.3 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Pharmaceutical Product Development, LLC
11.1.1 Pharmaceutical Product Development, LLC Company Details
11.1.2 Pharmaceutical Product Development, LLC Business Overview
11.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.1.5 Pharmaceutical Product Development, LLC Recent Developments
11.2 Drug Safety Solutions Limited
11.2.1 Drug Safety Solutions Limited Company Details
11.2.2 Drug Safety Solutions Limited Business Overview
11.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction
11.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.2.5 Drug Safety Solutions Limited Recent Developments
11.3 C3i
11.3.1 C3i Company Details
11.3.2 C3i Business Overview
11.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction
11.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.3.5 C3i Recent Developments
11.4 Worldwide Clinical Trials
11.4.1 Worldwide Clinical Trials Company Details
11.4.2 Worldwide Clinical Trials Business Overview
11.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction
11.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.4.5 Worldwide Clinical Trials Recent Developments
11.5 Bioclinica
11.5.1 Bioclinica Company Details
11.5.2 Bioclinica Business Overview
11.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction
11.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.5.5 Bioclinica Recent Developments
11.6 United Biosource LLC
11.6.1 United Biosource LLC Company Details
11.6.2 United Biosource LLC Business Overview
11.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.6.5 United Biosource LLC Recent Developments
11.7 Ennov
11.7.1 Ennov Company Details
11.7.2 Ennov Business Overview
11.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction
11.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.7.5 Ennov Recent Developments
11.8 AB Cube
11.8.1 AB Cube Company Details
11.8.2 AB Cube Business Overview
11.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction
11.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.8.5 AB Cube Recent Developments
11.9 Covance Inc.
11.9.1 Covance Inc. Company Details
11.9.2 Covance Inc. Business Overview
11.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.9.5 Covance Inc. Recent Developments
11.10 Accenture
11.10.1 Accenture Company Details
11.10.2 Accenture Business Overview
11.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction
11.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.10.5 Accenture Recent Developments
11.11 PRA Health Sciences, Inc.
11.11.1 PRA Health Sciences, Inc. Company Details
11.11.2 PRA Health Sciences, Inc. Business Overview
11.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.11.5 PRA Health Sciences, Inc. Recent Developments
11.12 Ergomed
11.12.1 Ergomed Company Details
11.12.2 Ergomed Business Overview
11.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction
11.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.12.5 Ergomed Recent Developments
11.13 IQVIA
11.13.1 IQVIA Company Details
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction
11.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.13.5 IQVIA Recent Developments
11.14 Genpact
11.14.1 Genpact Company Details
11.14.2 Genpact Business Overview
11.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction
11.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.14.5 Genpact Recent Developments
11.15 Cognizant
11.15.1 Cognizant Company Details
11.15.2 Cognizant Business Overview
11.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction
11.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.15.5 Cognizant Recent Developments
11.16 Parexel International Corporation
11.16.1 Parexel International Corporation Company Details
11.16.2 Parexel International Corporation Business Overview
11.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction
11.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.16.5 Parexel International Corporation Recent Developments
11.17 ArisGlobal
11.17.1 ArisGlobal Company Details
11.17.2 ArisGlobal Business Overview
11.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction
11.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.17.5 ArisGlobal Recent Developments
11.18 ICON plc
11.18.1 ICON plc Company Details
11.18.2 ICON plc Business Overview
11.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction
11.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.18.5 ICON plc Recent Developments
11.19 Oracle
11.19.1 Oracle Company Details
11.19.2 Oracle Business Overview
11.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction
11.19.4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.19.5 Oracle Recent Developments
11.20 Syneos Health
11.20.1 Syneos Health Company Details
11.20.2 Syneos Health Business Overview
11.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction
11.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.20.5 Syneos Health Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Standard Form
1.2.3 Customized Form
1.3 Market by Application
1.3.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization (CROS)
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Drug Safety Solutions and Pharmacovigilance Market Perspective (2018-2029)
2.2 Global Drug Safety Solutions and Pharmacovigilance Growth Trends by Region
2.2.1 Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Size by Region (2018-2023)
2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2024-2029)
2.3 Drug Safety Solutions and Pharmacovigilance Market Dynamics
2.3.1 Drug Safety Solutions and Pharmacovigilance Industry Trends
2.3.2 Drug Safety Solutions and Pharmacovigilance Market Drivers
2.3.3 Drug Safety Solutions and Pharmacovigilance Market Challenges
2.3.4 Drug Safety Solutions and Pharmacovigilance Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Drug Safety Solutions and Pharmacovigilance by Players
3.1.1 Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2018-2023)
3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2018-2023)
3.2 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio
3.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2022
3.5 Global Key Players of Drug Safety Solutions and Pharmacovigilance Head office and Area Served
3.6 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
3.7 Global Key Players of Drug Safety Solutions and Pharmacovigilance, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE BREAKDOWN DATA BY TYPE
4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2018-2023)
4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2024-2029)
5 DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE BREAKDOWN DATA BY APPLICATION
5.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2018-2023)
5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
6.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type
6.2.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
6.2.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
6.2.3 North America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application
6.3.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
6.3.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
6.3.3 North America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
6.4 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country
6.4.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023)
6.4.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
7.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type
7.2.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
7.2.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
7.2.3 Europe Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application
7.3.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
7.3.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
7.3.3 Europe Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
7.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country
7.4.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023)
7.4.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
8.2 China Drug Safety Solutions and Pharmacovigilance Market Size by Type
8.2.1 China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
8.2.2 China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
8.2.3 China Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
8.3 China Drug Safety Solutions and Pharmacovigilance Market Size by Application
8.3.1 China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
8.3.2 China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
8.3.3 China Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
9.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type
9.2.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
9.2.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
9.2.3 Asia Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
9.3 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application
9.3.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
9.3.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
9.3.3 Asia Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
9.4 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region
9.4.1 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2023)
9.4.3 Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Pharmaceutical Product Development, LLC
11.1.1 Pharmaceutical Product Development, LLC Company Details
11.1.2 Pharmaceutical Product Development, LLC Business Overview
11.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.1.5 Pharmaceutical Product Development, LLC Recent Developments
11.2 Drug Safety Solutions Limited
11.2.1 Drug Safety Solutions Limited Company Details
11.2.2 Drug Safety Solutions Limited Business Overview
11.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction
11.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.2.5 Drug Safety Solutions Limited Recent Developments
11.3 C3i
11.3.1 C3i Company Details
11.3.2 C3i Business Overview
11.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction
11.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.3.5 C3i Recent Developments
11.4 Worldwide Clinical Trials
11.4.1 Worldwide Clinical Trials Company Details
11.4.2 Worldwide Clinical Trials Business Overview
11.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction
11.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.4.5 Worldwide Clinical Trials Recent Developments
11.5 Bioclinica
11.5.1 Bioclinica Company Details
11.5.2 Bioclinica Business Overview
11.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction
11.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.5.5 Bioclinica Recent Developments
11.6 United Biosource LLC
11.6.1 United Biosource LLC Company Details
11.6.2 United Biosource LLC Business Overview
11.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction
11.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.6.5 United Biosource LLC Recent Developments
11.7 Ennov
11.7.1 Ennov Company Details
11.7.2 Ennov Business Overview
11.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction
11.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.7.5 Ennov Recent Developments
11.8 AB Cube
11.8.1 AB Cube Company Details
11.8.2 AB Cube Business Overview
11.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction
11.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.8.5 AB Cube Recent Developments
11.9 Covance Inc.
11.9.1 Covance Inc. Company Details
11.9.2 Covance Inc. Business Overview
11.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.9.5 Covance Inc. Recent Developments
11.10 Accenture
11.10.1 Accenture Company Details
11.10.2 Accenture Business Overview
11.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction
11.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.10.5 Accenture Recent Developments
11.11 PRA Health Sciences, Inc.
11.11.1 PRA Health Sciences, Inc. Company Details
11.11.2 PRA Health Sciences, Inc. Business Overview
11.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction
11.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.11.5 PRA Health Sciences, Inc. Recent Developments
11.12 Ergomed
11.12.1 Ergomed Company Details
11.12.2 Ergomed Business Overview
11.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction
11.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.12.5 Ergomed Recent Developments
11.13 IQVIA
11.13.1 IQVIA Company Details
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction
11.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.13.5 IQVIA Recent Developments
11.14 Genpact
11.14.1 Genpact Company Details
11.14.2 Genpact Business Overview
11.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction
11.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.14.5 Genpact Recent Developments
11.15 Cognizant
11.15.1 Cognizant Company Details
11.15.2 Cognizant Business Overview
11.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction
11.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.15.5 Cognizant Recent Developments
11.16 Parexel International Corporation
11.16.1 Parexel International Corporation Company Details
11.16.2 Parexel International Corporation Business Overview
11.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction
11.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.16.5 Parexel International Corporation Recent Developments
11.17 ArisGlobal
11.17.1 ArisGlobal Company Details
11.17.2 ArisGlobal Business Overview
11.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction
11.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.17.5 ArisGlobal Recent Developments
11.18 ICON plc
11.18.1 ICON plc Company Details
11.18.2 ICON plc Business Overview
11.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction
11.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.18.5 ICON plc Recent Developments
11.19 Oracle
11.19.1 Oracle Company Details
11.19.2 Oracle Business Overview
11.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction
11.19.4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.19.5 Oracle Recent Developments
11.20 Syneos Health
11.20.1 Syneos Health Company Details
11.20.2 Syneos Health Business Overview
11.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction
11.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
11.20.5 Syneos Health Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Standard Form
Table 3. Key Players of Customized Form
Table 4. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2018-2023)
Table 8. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2024-2029)
Table 10. Drug Safety Solutions and Pharmacovigilance Market Trends
Table 11. Drug Safety Solutions and Pharmacovigilance Market Drivers
Table 12. Drug Safety Solutions and Pharmacovigilance Market Challenges
Table 13. Drug Safety Solutions and Pharmacovigilance Market Restraints
Table 14. Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Players (2018-2023)
Table 16. Global Top Drug Safety Solutions and Pharmacovigilance by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2022)
Table 17. Global Drug Safety Solutions and Pharmacovigilance Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Headquarters and Area Served
Table 20. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
Table 21. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2024-2029)
Table 27. Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2018-2023)
Table 29. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2024-2029)
Table 31. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pharmaceutical Product Development, LLC Company Details
Table 64. Pharmaceutical Product Development, LLC Business Overview
Table 65. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product
Table 66. Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 67. Pharmaceutical Product Development, LLC Recent Developments
Table 68. Drug Safety Solutions Limited Company Details
Table 69. Drug Safety Solutions Limited Business Overview
Table 70. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product
Table 71. Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 72. Drug Safety Solutions Limited Recent Developments
Table 73. C3i Company Details
Table 74. C3i Business Overview
Table 75. C3i Drug Safety Solutions and Pharmacovigilance Product
Table 76. C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 77. C3i Recent Developments
Table 78. Worldwide Clinical Trials Company Details
Table 79. Worldwide Clinical Trials Business Overview
Table 80. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product
Table 81. Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 82. Worldwide Clinical Trials Recent Developments
Table 83. Bioclinica Company Details
Table 84. Bioclinica Business Overview
Table 85. Bioclinica Drug Safety Solutions and Pharmacovigilance Product
Table 86. Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 87. Bioclinica Recent Developments
Table 88. United Biosource LLC Company Details
Table 89. United Biosource LLC Business Overview
Table 90. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product
Table 91. United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 92. United Biosource LLC Recent Developments
Table 93. Ennov Company Details
Table 94. Ennov Business Overview
Table 95. Ennov Drug Safety Solutions and Pharmacovigilance Product
Table 96. Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 97. Ennov Recent Developments
Table 98. AB Cube Company Details
Table 99. AB Cube Business Overview
Table 100. AB Cube Drug Safety Solutions and Pharmacovigilance Product
Table 101. AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 102. AB Cube Recent Developments
Table 103. Covance Inc. Company Details
Table 104. Covance Inc. Business Overview
Table 105. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product
Table 106. Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 107. Covance Inc. Recent Developments
Table 108. Accenture Company Details
Table 109. Accenture Business Overview
Table 110. Accenture Drug Safety Solutions and Pharmacovigilance Product
Table 111. Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 112. Accenture Recent Developments
Table 113. PRA Health Sciences, Inc. Company Details
Table 114. PRA Health Sciences, Inc. Business Overview
Table 115. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product
Table 116. PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 117. PRA Health Sciences, Inc. Recent Developments
Table 118. Ergomed Company Details
Table 119. Ergomed Business Overview
Table 120. Ergomed Drug Safety Solutions and Pharmacovigilance Product
Table 121. Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 122. Ergomed Recent Developments
Table 123. IQVIA Company Details
Table 124. IQVIA Business Overview
Table 125. IQVIA Drug Safety Solutions and Pharmacovigilance Product
Table 126. IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 127. IQVIA Recent Developments
Table 128. Genpact Company Details
Table 129. Genpact Business Overview
Table 130. Genpact Drug Safety Solutions and Pharmacovigilance Product
Table 131. Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 132. Genpact Recent Developments
Table 133. Cognizant Company Details
Table 134. Cognizant Business Overview
Table 135. Cognizant Drug Safety Solutions and Pharmacovigilance Product
Table 136. Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 137. Cognizant Recent Developments
Table 138. Parexel International Corporation Company Details
Table 139. Parexel International Corporation Business Overview
Table 140. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product
Table 141. Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 142. Parexel International Corporation Recent Developments
Table 143. ArisGlobal Company Details
Table 144. ArisGlobal Business Overview
Table 145. ArisGlobal Drug Safety Solutions and Pharmacovigilance Product
Table 146. ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 147. ArisGlobal Recent Developments
Table 148. ICON plc Company Details
Table 149. ICON plc Business Overview
Table 150. ICON plc Drug Safety Solutions and Pharmacovigilance Product
Table 151. ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 152. ICON plc Recent Developments
Table 153. Oracle Company Details
Table 154. Oracle Business Overview
Table 155. Oracle Drug Safety Solutions and Pharmacovigilance Product
Table 156. Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 157. Oracle Recent Developments
Table 158. Syneos Health Company Details
Table 159. Syneos Health Business Overview
Table 160. Syneos Health Drug Safety Solutions and Pharmacovigilance Product
Table 161. Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 162. Syneos Health Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Standard Form
Table 3. Key Players of Customized Form
Table 4. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2018-2023)
Table 8. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2024-2029)
Table 10. Drug Safety Solutions and Pharmacovigilance Market Trends
Table 11. Drug Safety Solutions and Pharmacovigilance Market Drivers
Table 12. Drug Safety Solutions and Pharmacovigilance Market Challenges
Table 13. Drug Safety Solutions and Pharmacovigilance Market Restraints
Table 14. Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Players (2018-2023)
Table 16. Global Top Drug Safety Solutions and Pharmacovigilance by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2022)
Table 17. Global Drug Safety Solutions and Pharmacovigilance Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Headquarters and Area Served
Table 20. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
Table 21. Global Key Players of Drug Safety Solutions and Pharmacovigilance, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2024-2029)
Table 27. Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2018-2023)
Table 29. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application (2024-2029)
Table 31. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Drug Safety Solutions and Pharmacovigilance Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2024-2029) & (US$ Million)
Table 63. Pharmaceutical Product Development, LLC Company Details
Table 64. Pharmaceutical Product Development, LLC Business Overview
Table 65. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product
Table 66. Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 67. Pharmaceutical Product Development, LLC Recent Developments
Table 68. Drug Safety Solutions Limited Company Details
Table 69. Drug Safety Solutions Limited Business Overview
Table 70. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product
Table 71. Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 72. Drug Safety Solutions Limited Recent Developments
Table 73. C3i Company Details
Table 74. C3i Business Overview
Table 75. C3i Drug Safety Solutions and Pharmacovigilance Product
Table 76. C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 77. C3i Recent Developments
Table 78. Worldwide Clinical Trials Company Details
Table 79. Worldwide Clinical Trials Business Overview
Table 80. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product
Table 81. Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 82. Worldwide Clinical Trials Recent Developments
Table 83. Bioclinica Company Details
Table 84. Bioclinica Business Overview
Table 85. Bioclinica Drug Safety Solutions and Pharmacovigilance Product
Table 86. Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 87. Bioclinica Recent Developments
Table 88. United Biosource LLC Company Details
Table 89. United Biosource LLC Business Overview
Table 90. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product
Table 91. United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 92. United Biosource LLC Recent Developments
Table 93. Ennov Company Details
Table 94. Ennov Business Overview
Table 95. Ennov Drug Safety Solutions and Pharmacovigilance Product
Table 96. Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 97. Ennov Recent Developments
Table 98. AB Cube Company Details
Table 99. AB Cube Business Overview
Table 100. AB Cube Drug Safety Solutions and Pharmacovigilance Product
Table 101. AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 102. AB Cube Recent Developments
Table 103. Covance Inc. Company Details
Table 104. Covance Inc. Business Overview
Table 105. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product
Table 106. Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 107. Covance Inc. Recent Developments
Table 108. Accenture Company Details
Table 109. Accenture Business Overview
Table 110. Accenture Drug Safety Solutions and Pharmacovigilance Product
Table 111. Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 112. Accenture Recent Developments
Table 113. PRA Health Sciences, Inc. Company Details
Table 114. PRA Health Sciences, Inc. Business Overview
Table 115. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product
Table 116. PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 117. PRA Health Sciences, Inc. Recent Developments
Table 118. Ergomed Company Details
Table 119. Ergomed Business Overview
Table 120. Ergomed Drug Safety Solutions and Pharmacovigilance Product
Table 121. Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 122. Ergomed Recent Developments
Table 123. IQVIA Company Details
Table 124. IQVIA Business Overview
Table 125. IQVIA Drug Safety Solutions and Pharmacovigilance Product
Table 126. IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 127. IQVIA Recent Developments
Table 128. Genpact Company Details
Table 129. Genpact Business Overview
Table 130. Genpact Drug Safety Solutions and Pharmacovigilance Product
Table 131. Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 132. Genpact Recent Developments
Table 133. Cognizant Company Details
Table 134. Cognizant Business Overview
Table 135. Cognizant Drug Safety Solutions and Pharmacovigilance Product
Table 136. Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 137. Cognizant Recent Developments
Table 138. Parexel International Corporation Company Details
Table 139. Parexel International Corporation Business Overview
Table 140. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product
Table 141. Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 142. Parexel International Corporation Recent Developments
Table 143. ArisGlobal Company Details
Table 144. ArisGlobal Business Overview
Table 145. ArisGlobal Drug Safety Solutions and Pharmacovigilance Product
Table 146. ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 147. ArisGlobal Recent Developments
Table 148. ICON plc Company Details
Table 149. ICON plc Business Overview
Table 150. ICON plc Drug Safety Solutions and Pharmacovigilance Product
Table 151. ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 152. ICON plc Recent Developments
Table 153. Oracle Company Details
Table 154. Oracle Business Overview
Table 155. Oracle Drug Safety Solutions and Pharmacovigilance Product
Table 156. Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 157. Oracle Recent Developments
Table 158. Syneos Health Company Details
Table 159. Syneos Health Business Overview
Table 160. Syneos Health Drug Safety Solutions and Pharmacovigilance Product
Table 161. Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2018-2023) & (US$ Million)
Table 162. Syneos Health Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drug Safety Solutions and Pharmacovigilance Market Share by Type: 2022 VS 2029
Figure 3. Standard Form Features
Figure 4. Customized Form Features
Figure 5. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2022 VS 2029
Figure 7. Biotechnology and Pharmaceuticals Case Studies
Figure 8. Contract Research Organization (CROS) Case Studies
Figure 9. Hospital Case Studies
Figure 10. KPO / BPO Case Studies
Figure 11. Healthcare Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Safety Solutions and Pharmacovigilance Report Years Considered
Figure 14. Global Drug Safety Solutions and Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Drug Safety Solutions and Pharmacovigilance Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region: 2022 VS 2029
Figure 17. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players in 2022
Figure 18. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue in 2022
Figure 20. North America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 22. North America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 23. North America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2018-2029)
Figure 24. United States Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 28. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 29. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Country (2018-2029)
Figure 30. Germany Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 38. China Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 39. Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 41. Asia Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 42. Asia Drug Safety Solutions and Pharmacovigilance Market Share by Region (2018-2029)
Figure 43. Japan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2018-2029)
Figure 53. Brazil Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Pharmaceutical Product Development, LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 60. Drug Safety Solutions Limited Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 61. C3i Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 62. Worldwide Clinical Trials Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 63. Bioclinica Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 64. United Biosource LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 65. Ennov Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 66. AB Cube Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 67. Covance Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 68. Accenture Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 69. PRA Health Sciences, Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 70. Ergomed Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 71. IQVIA Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 72. Genpact Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 73. Cognizant Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 74. Parexel International Corporation Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 75. ArisGlobal Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 76. ICON plc Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 77. Oracle Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 78. Syneos Health Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Figure 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drug Safety Solutions and Pharmacovigilance Market Share by Type: 2022 VS 2029
Figure 3. Standard Form Features
Figure 4. Customized Form Features
Figure 5. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2022 VS 2029
Figure 7. Biotechnology and Pharmaceuticals Case Studies
Figure 8. Contract Research Organization (CROS) Case Studies
Figure 9. Hospital Case Studies
Figure 10. KPO / BPO Case Studies
Figure 11. Healthcare Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Safety Solutions and Pharmacovigilance Report Years Considered
Figure 14. Global Drug Safety Solutions and Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Drug Safety Solutions and Pharmacovigilance Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region: 2022 VS 2029
Figure 17. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players in 2022
Figure 18. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue in 2022
Figure 20. North America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 22. North America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 23. North America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2018-2029)
Figure 24. United States Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 28. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 29. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Country (2018-2029)
Figure 30. Germany Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 38. China Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 39. Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 41. Asia Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 42. Asia Drug Safety Solutions and Pharmacovigilance Market Share by Region (2018-2029)
Figure 43. Japan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2018-2029)
Figure 53. Brazil Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Pharmaceutical Product Development, LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 60. Drug Safety Solutions Limited Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 61. C3i Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 62. Worldwide Clinical Trials Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 63. Bioclinica Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 64. United Biosource LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 65. Ennov Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 66. AB Cube Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 67. Covance Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 68. Accenture Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 69. PRA Health Sciences, Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 70. Ergomed Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 71. IQVIA Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 72. Genpact Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 73. Cognizant Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 74. Parexel International Corporation Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 75. ArisGlobal Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 76. ICON plc Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 77. Oracle Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 78. Syneos Health Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2018-2023)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
